Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head …
J Martínez-Trufero, A Lozano Borbalas… - Clinical and …, 2021 - Springer
Abstract Background Sequential treatment of Panitumumab (Pb) plus Paclitaxel (Px) as
induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb may be an …
induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb may be an …
The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
This study evaluated the clinical characteristics of head and neck cancer (HNC) patients with
hepatitis B (HBV) or hepatitis C (HCV) who underwent concurrent chemoradiotherapy …
hepatitis B (HBV) or hepatitis C (HCV) who underwent concurrent chemoradiotherapy …
[HTML][HTML] Risk factors for oral mucositis in patients with solid tumors under treatment with cetuximab: a retrospective cross-sectional study
JO de Lima Martins, MMF Borges… - … Oral, Patología Oral y …, 2024 - ncbi.nlm.nih.gov
Results Among 1831 patients, OM was showed in 750 in any grade (41%), during cetuximab
treatment. Most patients were female (n= 944, 51.6%),< 70years-old (n= 1149, 62.8%), had …
treatment. Most patients were female (n= 944, 51.6%),< 70years-old (n= 1149, 62.8%), had …
Strategien zur Behandlung von Mundhöhlenkarzinomen
B Frerich - Der MKG-Chirurg, 2021 - Springer
Für die kurative Behandlung des Mundhöhlenkarzinoms stehen primär chirurgische und
nichtchirurgische Therapiestrategien zur Verfügung. In den frühen Stadien ist das alleinige …
nichtchirurgische Therapiestrategien zur Verfügung. In den frühen Stadien ist das alleinige …